DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Hutton DW, Stein JD, Glassman AR. et al.
Five-year cost-effectiveness of intravitreous ranibizumab therapy vs. panretinal photocoagulation for treating proliferative diabetic retinopathy: a secondary analysis of a randomized clinical trial.
JAMA Ophthalmol 2019;
24: 1-9
doi:10.1001/jamaophthalmol.2019.4284
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.